1. Home
  2. PNNT vs MRVI Comparison

PNNT vs MRVI Comparison

Compare PNNT & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PNNT
  • MRVI
  • Stock Information
  • Founded
  • PNNT 2007
  • MRVI 2014
  • Country
  • PNNT United States
  • MRVI United States
  • Employees
  • PNNT N/A
  • MRVI N/A
  • Industry
  • PNNT Finance: Consumer Services
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • PNNT Finance
  • MRVI Health Care
  • Exchange
  • PNNT Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • PNNT 457.1M
  • MRVI 376.2M
  • IPO Year
  • PNNT 2007
  • MRVI 2020
  • Fundamental
  • Price
  • PNNT $6.80
  • MRVI $2.81
  • Analyst Decision
  • PNNT Sell
  • MRVI Hold
  • Analyst Count
  • PNNT 4
  • MRVI 9
  • Target Price
  • PNNT $6.33
  • MRVI $5.25
  • AVG Volume (30 Days)
  • PNNT 459.7K
  • MRVI 940.3K
  • Earning Date
  • PNNT 08-11-2025
  • MRVI 11-06-2025
  • Dividend Yield
  • PNNT 14.07%
  • MRVI N/A
  • EPS Growth
  • PNNT 21.65
  • MRVI N/A
  • EPS
  • PNNT 0.80
  • MRVI N/A
  • Revenue
  • PNNT $130,923,000.00
  • MRVI $219,830,000.00
  • Revenue This Year
  • PNNT N/A
  • MRVI N/A
  • Revenue Next Year
  • PNNT N/A
  • MRVI $7.23
  • P/E Ratio
  • PNNT $8.56
  • MRVI N/A
  • Revenue Growth
  • PNNT N/A
  • MRVI N/A
  • 52 Week Low
  • PNNT $5.72
  • MRVI $1.67
  • 52 Week High
  • PNNT $7.53
  • MRVI $9.50
  • Technical
  • Relative Strength Index (RSI)
  • PNNT 25.76
  • MRVI 60.20
  • Support Level
  • PNNT $7.11
  • MRVI $2.61
  • Resistance Level
  • PNNT $7.29
  • MRVI $2.80
  • Average True Range (ATR)
  • PNNT 0.09
  • MRVI 0.16
  • MACD
  • PNNT -0.04
  • MRVI 0.04
  • Stochastic Oscillator
  • PNNT 1.00
  • MRVI 76.09

About PNNT PennantPark Investment Corporation

Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: